Glenmark Life Sciences

Mumbai, India Founded: 2011 • Age: 15 yrs Acquired By Nirma
API manufacturing is provided by the CDMO in India.

About Glenmark Life Sciences

Glenmark Life Sciences is a company based in Mumbai (India) founded in 2011 was acquired by Nirma in September 2023.. The company has 3,940 employees as of March 31, 2024. Glenmark Life Sciences offers products and services including Active Pharmaceutical Ingredients and CDMO Services. Glenmark Life Sciences operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.

  • Headquarter Mumbai, India
  • Employees 3940 as on 31 Mar, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Alivus Life Sciences Ltd
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
    $277.1 M (USD)
    4.48
    as on Mar 31, 2024
  • Net Profit
    $56.78 M (USD)
    3.13
    as on Mar 31, 2024
  • EBITDA
    $79.67 M (USD)
    1.18
    as on Mar 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    3940

    as on Mar 31, 2024

  • Acquired by
    Nirma

    (Sep 21, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Glenmark Life Sciences

Glenmark Life Sciences is a publicly listed company on the NSE with ticker symbol ALIVUS in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: ALIVUS . Sector: Health technology · India

Products & Services of Glenmark Life Sciences

Glenmark Life Sciences offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients and CDMO Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Develops high-quality APIs for chronic disease treatments globally.

Provides end-to-end support for API and intermediate manufacturing.

People of Glenmark Life Sciences
Headcount 1000-5000
Employee Profiles 17
Employee Profiles
People
Aditya Kumar Soren
Human Resources Manager
People
Vijay Mahajan
Quality Control Executive
People
Mihir Doshi
Vice President - Europe & Japan
People
Tushar Mistry
Chief Financial Officer & Senior Vice President

Unlock access to complete

Funding Insights of Glenmark Life Sciences

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Glenmark Life Sciences

Glenmark Life Sciences has secured backing from 1 investor. Prominent investors backing the company include Nirma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Manufactures and markets consumer care products for everyday use.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Glenmark Life Sciences

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Glenmark Life Sciences

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Glenmark Life Sciences Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Glenmark Life Sciences

Glenmark Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Pharmaceutical and biotechnology company
domain founded_year HQ Location
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
domain founded_year HQ Location
APIs and drug products are developed and valorized in pharmaceuticals.
domain founded_year HQ Location
APIs, intermediates, and biochemical reagents are developed and manufactured.
domain founded_year HQ Location
APIs are developed and manufactured for therapeutic areas.
domain founded_year HQ Location
Contract development, manufacturing, and analytical services for APIs are offered.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Glenmark Life Sciences

Frequently Asked Questions about Glenmark Life Sciences

When was Glenmark Life Sciences founded?

Glenmark Life Sciences was founded in 2011.

Where is Glenmark Life Sciences located?

Glenmark Life Sciences is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Who is the current CEO of Glenmark Life Sciences?

Yasir Rawjee is the current CEO of Glenmark Life Sciences.

How many employees does Glenmark Life Sciences have?

As of Mar 31, 2024, the latest employee count at Glenmark Life Sciences is 3,940.

What is the annual revenue of Glenmark Life Sciences?

Annual revenue of Glenmark Life Sciences is $277.1M as on Mar 31, 2024.

What does Glenmark Life Sciences do?

Glenmark Life Sciences was founded in 2011 and is headquartered in Mumbai, India. Operations are centered on contract development and manufacturing organization (CDMO) services for active pharmaceutical ingredients (APIs). The company supports pharmaceutical production through API synthesis and supply, serving global clients in the healthcare sector. Leadership is provided by Yasir Rawjee as CEO and Managing Director.

Who are the top competitors of Glenmark Life Sciences?

Glenmark Life Sciences's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.

What products or services does Glenmark Life Sciences offer?

Glenmark Life Sciences offers Active Pharmaceutical Ingredients and CDMO Services.

Is Glenmark Life Sciences publicly traded?

Yes, Glenmark Life Sciences is publicly traded on NSE under the ticker symbol ALIVUS.

Who are Glenmark Life Sciences's investors?

Glenmark Life Sciences has 1 investor. Key investors include Nirma.

What is Glenmark Life Sciences's ticker symbol?

The ticker symbol of Glenmark Life Sciences is ALIVUS on NSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available